← All trials
NCT05800977
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 22, 2023
- Primary completion
- Mar 31, 2027
- Completion date
- Mar 31, 2027
- First posted
- Apr 6, 2023
- Last posted
- Apr 6, 2023
- Enrollment
- 72
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- AbelZetaLead sponsor
- Cellular Biomedicine Group Ltd.Lead sponsor
- Jiao Tong UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.